Munshi S K, Vijayakumar N, Taub N A, Bhullar H, Lo T C, Warwick G
Departments of Nephrology and. Medicine for the Elderly, Leicester General Hospital, Gwendolen Road, Leicester, UK.
Nephrol Dial Transplant. 2001 Jan;16(1):128-33. doi: 10.1093/ndt/16.1.128.
In a retrospective case-note and computer database analysis we assessed the outcome of very elderly patients (> or = 75 years old) with end-stage renal disease (ESRD) on renal replacement therapy (RRT).
Fifty-eight individuals aged 75 or over (group 1) commenced RRT between 1 January 1991 and 31 December 1995. Comparisons were made with other patients commencing RRT who were divided into two groups: group 2 (201 individuals 65-74 years old) and group 3 (379 patients <65 years old). All subjects were followed up until the point of assessment (30 June 1998), the time of death, or withdrawal from dialysis. Survival rates in the three groups were compared using Kaplan-Meier method. The number of hospital admissions, length of in-patient stay, and complications rate on RRT were assessed for group 1.
One-year survival rates in groups 1, 2 and 3 were 53.5, 72.6, and 90.6% respectively and the 5-year survival rates were 2.4, 18.8, and 61.4% respectively. The very elderly spent 20% of their time in hospital, 46% had two co-morbid factors at the outset, and 26% developed multiple complications while on RRT. Withdrawal from dialysis remained the most common cause of death in this group of individuals (38%), followed by cardiovascular causes (24%) and infections (22%).
Very elderly ESRD patients on RRT have a very poor outcome and, since they are the largest growing group of RRT patients, this has important implications for future health policies.
在一项回顾性病例记录和计算机数据库分析中,我们评估了接受肾脏替代治疗(RRT)的终末期肾病(ESRD)高龄患者(≥75岁)的治疗结果。
58名75岁及以上的患者(第1组)于1991年1月1日至1995年12月31日开始接受RRT治疗。将其与开始接受RRT治疗的其他患者进行比较,这些患者分为两组:第2组(201名65 - 74岁患者)和第3组(379名<65岁患者)。所有受试者均随访至评估时间(1998年6月30日)、死亡时间或停止透析。使用Kaplan-Meier方法比较三组的生存率。评估第1组患者的住院次数、住院时间和RRT治疗的并发症发生率。
第1、2和3组的1年生存率分别为53.5%、72.6%和90.6%,5年生存率分别为2.4%、18.8%和61.4%。高龄患者有20%的时间住院,46%的患者一开始就有两种合并症,26%的患者在接受RRT治疗时出现多种并发症。停止透析仍然是该组患者最常见的死亡原因(38%),其次是心血管原因(24%)和感染(22%)。
接受RRT治疗的高龄ESRD患者预后很差,而且由于他们是接受RRT治疗的患者中增长最快的群体,这对未来的卫生政策具有重要意义。